TABLE 7.

Time on Study

Group	No.	Time on Study Median (Minimum-Maximum), Months
All patients	55	5.6 (0.4–38.3a)
Bortezomib refractory	28	3.0 (0.4–38.3a)
PI refractory	31	3.7 (0.4–38.3a)
PI sensitive	23	6.9 (1.2–26.7a)
Low AAG (≤110 mg/dL)	40	5.7 (0.9–38.3a)
High AAG (>110 mg/dL)	12	2.6 (0.4–14.5)
Low AAG and PI refractory	22	4.8 (0.9–38.3a)
High AAG and PI refractory	8	2.3 (0.4–8.5)
Low AAG and PI sensitive	17	6.9 (1.9–26.7a)
High AAG and PI sensitive	4	9.5 (1.2–14.5)

Abbreviations: AAG, alpha 1-acid glycoprotein; PI, proteasome inhibitor.

^aIndicates censoring.